Autologous Platelet-rich Plasma (PRP) and Thrombin Coagulum for the Topical Treatment of Rectal Mucosal Ulcers

NCT05912712 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Ulcerative Colitis Chronic Moderate
Ulcerative Colitis Chronic Severe
Rectal Ulcer

Interventions

OTHER: Autologous Platelet-rich Plasma (PRP) and Thrombin Coagulum Treatment
OTHER: Autologous Platelet-poor Plasma (PPP) and Thrombin Coagulum Treatment
DRUG: Mesalazine Suppository Treatment
BIOLOGICAL: Infliximab Treatment

Sponsor

Xijing Hospital of Digestive Diseases